Education
About Us
Working with TipRanks
Follow Us
Sonoma Pharmaceuticals, Inc. (SNOA)
:SNOA
Total Valuation
Sonoma Pharmaceuticals has a market cap or net worth of $5.24M. The enterprise value is -$27.32K.
Market Cap$5.24M
Enterprise Value-$27.32K
Share Statistics
Sonoma Pharmaceuticals has 1,615,765 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,615,765
Owned by Insiders31.44%
Owned by Institutions0.64%
Financial Efficiency
Sonoma Pharmaceuticals’s return on equity (ROE) is -0.79 and return on invested capital (ROIC) is -39.14%.
Return on Equity (ROE)-0.79
Return on Assets (ROA)-0.33
Return on Invested Capital (ROIC)-39.14%
Return on Capital Employed (ROCE)-0.43
Revenue Per Employee1.27M
Profits Per Employee-483.50K
Employee Count10
Asset Turnover0.86
Inventory Turnover2.94
Valuation Ratios
The current PE Ratio of Sonoma Pharmaceuticals is -0.58. Sonoma Pharmaceuticals’s PEG ratio is -0.06.
PE Ratio-0.58
PS Ratio0.00
PB Ratio0.95
Price to Fair Value0.45
Price to FCF39.45
Price to Operating Cash Flow29.00
PEG Ratio-0.06
Income Statement
In the last 12 months, Sonoma Pharmaceuticals had revenue of 12.73M and earned -4.83M in profits. Earnings per share was -5.32.
Revenue12.73M
Gross Profit4.75M
Operating Income-4.70M
Pretax Income-5.03M
Net Income-4.83M
EBITDA-4.53M
Earnings Per Share (EPS)-5.32
Cash Flow
In the last 12 months, operating cash flow was 1.07M and capital expenditures -25.00K, giving a free cash flow of 1.05M billion.
Operating Cash Flow1.07M
Free Cash Flow1.05M
Free Cash Flow per Share0.65
Dividends & Yields
Sonoma Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.54
52-Week Price Change-17.34%
50-Day Moving Average3.00
200-Day Moving Average3.07
Relative Strength Index (RSI)54.49
Average Volume (3m)2.39M
Important Dates
Sonoma Pharmaceuticals upcoming earnings date is Jul 9, 2025, TBA Not Confirmed.
Last Earnings DateFeb 5, 2025
Next Earnings DateJul 9, 2025
Ex-Dividend Date―
Financial Position
Sonoma Pharmaceuticals as a current ratio of 3.37, with Debt / Equity ratio of 2.44%
Current Ratio3.37
Quick Ratio2.64
Debt to Market Cap0.12
Net Debt to EBITDA0.56
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Sonoma Pharmaceuticals has paid -196.00K in taxes.
Income Tax-196.00K
Effective Tax Rate0.04
Enterprise Valuation
Sonoma Pharmaceuticals EV to EBITDA ratio is -0.06, with an EV/FCF ratio of -0.11.
EV to Sales0.02
EV to EBITDA-0.06
EV to Free Cash Flow-0.11
EV to Operating Cash Flow-0.11
Balance Sheet
Sonoma Pharmaceuticals has $5.24M in cash and marketable securities with $119.00K in debt, giving a net cash position of -$5.12M billion.
Cash & Marketable Securities$5.24M
Total Debt$119.00K
Net Cash-$5.12M
Net Cash Per Share-$3.17
Tangible Book Value Per Share$6.75
Margins
Gross margin is 35.98%, with operating margin of -36.91%, and net profit margin of -37.97%.
Gross Margin35.98%
Operating Margin-36.91%
Pretax Margin-39.51%
Net Profit Margin-37.97%
EBITDA Margin-35.53%
EBIT Margin-36.91%
Analyst Forecast
The average price target for Sonoma Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast13.51%
EPS Growth Forecast78.93%